Ocera Therapeutics
contact us
  • home
  • about us
  • pipeline
  • therapeutic areas
  • clinical trials
  • partnering and licensing
  • news and events
  • Overview
  • Liver
    • Mild HE
    • Acute HE in Liver Cirrhosis
    • Acute HE in Acute Liver Failure
  • GI
    • Pouchitis
    • IBS

Therapeutic Areas

Overview

Ocera’s mission is to develop safe and novel compounds to treat liver and gastrointestinal diseases.

Among various therapeutic targets, our current pipeline addresses the therapeutic areas of hepatic encephalopathy (mild and acute), acute liver failure, irritable bowel syndrome and pouchitis.

Mild Hepatic Encephalopathy
Acute Hepatic Encephalopathy in Liver Cirrhosis
Acute Hepatic Encephalopathy in Acute Liver Failure
Irritable Bowel Syndrome
Pouchitis

 

$('.clickable').fitted();

 

Copyright © 2010 Ocera Therapeutics, Inc.